These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32449435)

  • 1. Burkitt lymphoma-related
    Yamazaki T; Liu L; Conlon EG; Manley JL
    RNA Biol; 2020 Oct; 17(10):1383-1390. PubMed ID: 32449435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCF3 mutually exclusive alternative splicing is controlled by long-range cooperative actions between hnRNPH1 and PTBP1.
    Yamazaki T; Liu L; Manley JL
    RNA; 2019 Nov; 25(11):1497-1508. PubMed ID: 31391218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.
    Yamazaki T; Liu L; Lazarev D; Al-Zain A; Fomin V; Yeung PL; Chambers SM; Lu CW; Studer L; Manley JL
    Genes Dev; 2018 Sep; 32(17-18):1161-1174. PubMed ID: 30115631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
    Schmitz R; Young RM; Ceribelli M; Jhavar S; Xiao W; Zhang M; Wright G; Shaffer AL; Hodson DJ; Buras E; Liu X; Powell J; Yang Y; Xu W; Zhao H; Kohlhammer H; Rosenwald A; Kluin P; Müller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Ogwang MD; Reynolds SJ; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pittaluga S; Wilson W; Waldmann TA; Rowe M; Mbulaiteye SM; Rickinson AB; Staudt LM
    Nature; 2012 Oct; 490(7418):116-20. PubMed ID: 22885699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis.
    Dong L; Huang J; Zu P; Liu J; Gao X; Du J; Li Y
    Bioengineered; 2021 Dec; 12(1):7995-8005. PubMed ID: 34658308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
    Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
    Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.
    Wilke AC; Doebele C; Zindel A; Lee KS; Rieke SA; Ceribelli M; Comoglio F; Phelan JD; Wang JQ; Pikman Y; Jahn D; Häupl B; Schneider C; Scheich S; Tosto FA; Bohnenberger H; Stauder P; Schnütgen F; Slabicki M; Coulibaly ZA; Wolf S; Bojarczuk K; Chapuy B; Brandts CH; Stroebel P; Lewis CA; Engelke M; Xu X; Kim H; Dang TH; Schmitz R; Hodson DJ; Stegmaier K; Urlaub H; Serve H; Schmitt CA; Kreuz F; Knittel G; Rabinowitz JD; Reinhardt HC; Vander Heiden MG; Thomas C; Staudt LM; Zenz T; Oellerich T
    Blood; 2022 Jan; 139(4):538-553. PubMed ID: 34624079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.
    López C; Kleinheinz K; Aukema SM; Rohde M; Bernhart SH; Hübschmann D; Wagener R; Toprak UH; Raimondi F; Kreuz M; Waszak SM; Huang Z; Sieverling L; Paramasivam N; Seufert J; Sungalee S; Russell RB; Bausinger J; Kretzmer H; Ammerpohl O; Bergmann AK; Binder H; Borkhardt A; Brors B; Claviez A; Doose G; Feuerbach L; Haake A; Hansmann ML; Hoell J; Hummel M; Korbel JO; Lawerenz C; Lenze D; Radlwimmer B; Richter J; Rosenstiel P; Rosenwald A; Schilhabel MB; Stein H; Stilgenbauer S; Stadler PF; Szczepanowski M; Weniger MA; Zapatka M; Eils R; Lichter P; Loeffler M; Möller P; Trümper L; Klapper W; ; Hoffmann S; Küppers R; Burkhardt B; Schlesner M; Siebert R
    Nat Commun; 2019 Mar; 10(1):1459. PubMed ID: 30926794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic and endemic Burkitt lymphoma have frequent
    Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
    Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.
    Wagener R; Aukema SM; Schlesner M; Haake A; Burkhardt B; Claviez A; Drexler HG; Hummel M; Kreuz M; Loeffler M; Rosolowski M; López C; Möller P; Richter J; Rohde M; Betts MJ; Russell RB; Bernhart SH; Hoffmann S; Rosenstiel P; Schilhabel M; Szczepanowski M; Trümper L; Klapper W; Siebert R; ;
    Genes Chromosomes Cancer; 2015 Sep; 54(9):555-64. PubMed ID: 26173642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional analysis of porcine basic helix-loop-helix transcriptional factor 3 (TCF3) and its alternative splicing isoforms.
    Yang F; Wang N; Liu Y; Wang H
    Res Vet Sci; 2016 Apr; 105():1-4. PubMed ID: 27033898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of TCF3 in Burkitt's Lymphoma and Its Proliferative Effect and Prognostic Significance].
    Dong LH; Huang JJ; Liu J; Gao X; DU JW; Li YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1435-1439. PubMed ID: 36208246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Burkitt Lymphoma.
    Dunleavy K; Little RF; Wilson WH
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1333-1343. PubMed ID: 27888884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma.
    Seitz V; Butzhammer P; Hirsch B; Hecht J; Gütgemann I; Ehlers A; Lenze D; Oker E; Sommerfeld A; von der Wall E; König C; Zinser C; Spang R; Hummel M
    PLoS One; 2011; 6(11):e26837. PubMed ID: 22102868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
    Penther D; Viailly PJ; Latour S; Etancelin P; Bohers E; Vellemans H; Camus V; Menard AL; Coutant S; Lanic H; Lemasle E; Drieux F; Veresezan L; Ruminy P; Raimbault A; Soulier J; Frebourg T; Tilly H; Jardin F
    Genes Chromosomes Cancer; 2019 Aug; 58(8):595-601. PubMed ID: 30779244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
    Amato T; Abate F; Piccaluga P; Iacono M; Fallerini C; Renieri A; De Falco G; Ambrosio MR; Mourmouras V; Ogwang M; Calbi V; Rabadan R; Hummel M; Pileri S; Leoncini L; Bellan C
    Am J Clin Pathol; 2016 Jan; 145(1):116-27. PubMed ID: 26712879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.